Eye blood flow may reveal glaucoma before vision loss
NCT ID NCT05344274
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether measuring blood flow in the retina can help detect early glaucoma. Researchers will use special dyes and imaging to see how blood vessels respond to oxygen. The goal is to find a reliable early warning sign for the disease. About 90 adults with early glaucoma or healthy eyes will take part.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Indocyanine green dye and oxygen supplementation
- What this could lead to
- If successful, this could lead to a simple, non-invasive test to detect glaucoma earlier, potentially preventing vision loss.
- What could go wrong
- This is a small, early-phase study focused on finding a biomarker, not a treatment. The results may not translate into a widely usable test.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2022
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 88 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. age over 18 years 2. open angle in gonioscopy (grade 3 or 4 in Shaffer classification) 3. refractive error within the range of +3.00 to -8.00 diopters (4) best-corrected visual acuity 20/25 or better (5) Individuals recruited will be in one of the 3 groups: 1\) Early Glaucoma as per Hodapp-Anderson-Parrish Criteria (54). Early glaucoma subjects specifically with visual field defects restricted to one side of the horizontal midline will be selected to allow for comparison of rates of progression in both hemifields. Individuals will need to be off of glaucoma medications for four weeks to participate in the study. 2) Pre-perimetric glaucoma defined as the presence of glaucomatous optic nerve damage (e.g., focal notching, rim thinning), RNFL defect, and the absence of a definite glaucomatous visual field defect using standard automated perimetry at the three most recent consecutive examinations. A glaucomatous visual field defect is defined as either 3 or more abnormal points with a P\<0.05, of which at least 1 point has a pattern standard deviation (PSD) of P\<0.01; or a PSD of P\<0.05; or glaucoma hemifield test values outside the normal limits. (55,56) 3) Control group - A subject with no family history of glaucoma who has the following: a) OCT with all four quadrants within the normal range for age-matched controls, b) reliable visual fields with glaucoma hemifield test within normal limits and determined to be normal by a glaucoma specialist, and c) cup-to-disc ratio of 0.4 or lower and asymmetry of the cup to disc ratio no greater than 0.1 as determined by a glaucoma specialist. Control subjects will be age matched to the early glaucoma subjects. Exclusion Criteria: 1. corneal abnormalities or other conditions preventing reliable applanation tonometry 2. retinal disease affecting retinal nerve fiber layer thickness such as vitreomacular traction as determined by a glaucoma specialist 3. secondary glaucoma 4. history of prior ocular surgery other than uncomplicated cataract surgery or laser trabeculoplasty 5. inability to safely be off of glaucoma medications for 4 weeks 6. inability to obtain OCT angiography data due to excessive eye motion or inability to fixate 7. unreliable visual fields 8. any history of smoking in the past 6 months 9. cataract greater than lens opacity classification system (LOCS) II Grade≥2 10. diagnosis of diabetes, hypertension, or other known vascular disorder such as vasculitis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Glaucoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
4 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Food and Drug Administration (FDA)
RECRUITINGSilver Spring, Maryland, 20903, United States
-
University of Maryland Faculty Physicians, Inc
RECRUITINGBaltimore, Maryland, 21201, United States
-
University of Maryland Medical Center
RECRUITINGBaltimore, Maryland, 21201, United States
-
University of Maryland, Baltimore
RECRUITINGBaltimore, Maryland, 21201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can exercise shield the eyes of glaucoma patients?
- One operation for cataract and glaucoma? eye surgeons test a Two-in-One approach
- Can better Follow-Up schedules save sight in glaucoma?
- Portable devices could take the guesswork out of eye pressure checks
- Eye drops may shield the cornea after cataract surgery
- Can a puff of air replace the eye pressure probe?